405 related articles for article (PubMed ID: 36986748)
1. Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers.
Kumar G; Virmani T; Sharma A; Pathak K
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986748
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Phyto-drug conjugated nanomaterials enhance apoptotic activity in cancer.
Vimala K; Kannan S
Adv Protein Chem Struct Biol; 2021; 125():275-305. PubMed ID: 33931143
[TBL] [Abstract][Full Text] [Related]
4. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.
Gao Q; Feng J; Liu W; Wen C; Wu Y; Liao Q; Zou L; Sui X; Xie T; Zhang J; Hu Y
Adv Drug Deliv Rev; 2022 Sep; 188():114445. PubMed ID: 35820601
[TBL] [Abstract][Full Text] [Related]
5. Switching from Conventional to Nano-natural Phytochemicals to Prevent and Treat Cancers: Special Emphasis on Resveratrol.
Salman Ul Islam ; Ahmed MB; Mazhar Ul-Islam ; Shehzad A; Lee YS
Curr Pharm Des; 2019; 25(34):3620-3632. PubMed ID: 31605574
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer.
Gurunathan S; Kang MH; Qasim M; Kim JH
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347840
[TBL] [Abstract][Full Text] [Related]
7. Nanocarriers for anticancer drugs--new trends in nanomedicine.
Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
[TBL] [Abstract][Full Text] [Related]
8. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.
Wang S; Su R; Nie S; Sun M; Zhang J; Wu D; Moustaid-Moussa N
J Nutr Biochem; 2014 Apr; 25(4):363-76. PubMed ID: 24406273
[TBL] [Abstract][Full Text] [Related]
9. Phytofabricated Nanoparticle Formulation for Cancer Treatment: A Comprehensive Review.
Verma M; Fatima S; Ansari IA
Curr Drug Metab; 2022; 23(10):818-826. PubMed ID: 35490313
[TBL] [Abstract][Full Text] [Related]
10. Cancer chemotherapy with lipid-based nanocarriers.
Liu D; Zhang N
Crit Rev Ther Drug Carrier Syst; 2010; 27(5):371-417. PubMed ID: 21083528
[TBL] [Abstract][Full Text] [Related]
11. Phytofabrication of Nanoparticles as Novel Drugs for Anticancer Applications.
Wei QY; He KM; Chen JL; Xu YM; Lau ATY
Molecules; 2019 Nov; 24(23):. PubMed ID: 31766544
[TBL] [Abstract][Full Text] [Related]
12. Reports of Plant-Derived Nanoparticles for Prostate Cancer Therapy.
Elbagory AM; Hull R; Meyer M; Dlamini Z
Plants (Basel); 2023 May; 12(9):. PubMed ID: 37176928
[TBL] [Abstract][Full Text] [Related]
13. A Mini-Review on Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Topical Delivery of Phytochemicals for the Treatment of
Chutoprapat R; Kopongpanich P; Chan LW
Molecules; 2022 May; 27(11):. PubMed ID: 35684396
[No Abstract] [Full Text] [Related]
14. Recent Advances of Nanotechnology in the Diagnosis and Therapy of Triple- Negative Breast Cancer (TNBC).
Kanugo A; Gautam RK; Kamal MA
Curr Pharm Biotechnol; 2022; 23(13):1581-1595. PubMed ID: 34967294
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
16. Polymeric Nanocarriers: A New Horizon for the Effective Management of Breast Cancer.
Khan I; Kumar H; Mishra G; Gothwal A; Kesharwani P; Gupta U
Curr Pharm Des; 2017; 23(35):5315-5326. PubMed ID: 28875848
[TBL] [Abstract][Full Text] [Related]
17. Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons.
Majidinia M; Mirza-Aghazadeh-Attari M; Rahimi M; Mihanfar A; Karimian A; Safa A; Yousefi B
IUBMB Life; 2020 May; 72(5):855-871. PubMed ID: 31913572
[TBL] [Abstract][Full Text] [Related]
18. Targeting Cancer Via Resveratrol-Loaded Nanoparticles Administration: Focusing on In Vivo Evidence.
Santos AC; Pereira I; Magalhães M; Pereira-Silva M; Caldas M; Ferreira L; Figueiras A; Ribeiro AJ; Veiga F
AAPS J; 2019 Apr; 21(4):57. PubMed ID: 31016543
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnological breakthroughs in the development of topical phytocompounds-based formulations.
Santos AC; Rodrigues D; Sequeira JAD; Pereira I; Simões A; Costa D; Peixoto D; Costa G; Veiga F
Int J Pharm; 2019 Dec; 572():118787. PubMed ID: 31678376
[TBL] [Abstract][Full Text] [Related]
20. Micelles as potential drug delivery systems for colorectal cancer treatment.
Fatfat Z; Fatfat M; Gali-Muhtasib H
World J Gastroenterol; 2022 Jul; 28(25):2867-2880. PubMed ID: 35978871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
